Elite Pharmaceuticals Inc
ELTP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001053369
In the last 90 days, Elite Pharmaceuticals Inc insiders filed 1 open-market purchase and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $365 in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Elite Pharmaceuticals Inc changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 0 | 1 | +1 |
| Shares | 0 | 5.18K | +5.18K |
| Value | $0 | $2.25K | +$2.25K |
New holders (1)
Institutions that held Elite Pharmaceuticals Inc at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ancora Advisors, LLC | 5,182 | $2.25K | 0.00% |
Sold out (0)
Institutions that held Elite Pharmaceuticals Inc at the end of Q4 2024 and filed for Q1 2025 without it.
None.